Compass Pathways' depression treatment meets main goal in late‑stage study

Feb 17 (Reuters) - Drug developer Compass Pathways said on Tuesday its psilocybin-based depression therapy reduced the severity of symptoms in a late-stage study, sending its shares up nearly 30%. The ...
BioSpace

Ocular’s Hydrogel Beats Regeneron’s Eylea in Wet AMD Study, Plots Path to FDA

Following the successful late-stage study in wet age-related macular degeneration, Ocular plans to meet with the FDA to ...

Class Action Announcement for uniQure N.V. Investors: Kessler Topaz Meltzer & Check, LLP Has Filed a Securities Fraud Class Action Lawsuit Against uniQure N.V.

Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against uniQure N.V. (NASDAQ: QURE) (“uniQure” or the “Company”) on behalf of ...
Electronic Specifier

MCU family plots route to 32-bit designs

The Microchip Technology PIC32CM PL10 family provides a straightforward path for engineers moving designs from 8-bit ...
Onrec

Inside Quality Inspection Jobs at Top Plastic Molding Companies

Quality inspection at a plastic molding company starts with measurement tools that would look at home in a science lab. Coordinate measuring machines, optical comparators, and laser micrometers are ...